Interestingly, a higher CD4+/CD8+ ratio (i.e., a higher CD4+ cell count) in peripheral blood had a beneficial effect on the effectiveness of therapy, including radiation therapy in patients with rectal cancer [26]. This evidence concerns the gene CD8A and rectal cancer.